J Liver Cancer.  2016 Sep;16(2):82-85. 10.17998/jlc.2016.16.2.82.

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis

• Kim JS
• Park SC

• KMID: 2357336
• DOI: http://doi.org/10.17998/jlc.2016.16.2.82

Abstract

Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.

Keyword

Hepatocellular carcinoma; Extrahepatic metastasis; Transarterial chemoembolization

MeSH Terms

Carcinoma, Hepatocellular*
Cause of Death
Humans
Liver Failure
Neoplasm Metastasis*